Literature DB >> 2739689

Histopathology of chromoblastomycosis.

F Uribe1, A I Zuluaga, W Leon, A Restrepo.   

Abstract

A study aimed at determining the histopathologic appearance of chromoblastomycotic lesions was undertaken. Biopsies from 26 patients with the disease were examined. It was found that 23 cases (88.46%) exhibited the organized mixed mycotic granuloma - OMMA -, a granuloma modified by the presence polymorphonuclear neutrophils - PMN's. An equal proportion of cases exhibited pseudoepitheliomatous hyperplasia, with the epithelium playing an important role in the transepidermic elimination of the fungus. Healing of the lesions took place by fibrosis which was observed in 21 (80.77%) patients; this type of reaction was more common in the deeper areas of the dermis.

Entities:  

Mesh:

Year:  1989        PMID: 2739689     DOI: 10.1007/bf00443822

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  7 in total

1.  Histopathology of cutaneous and mucosal lesions in human paracoccidioidomycosis.

Authors:  F Uribe; A I Zuluaga; W León; A Restrepo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1987 Mar-Apr       Impact factor: 1.846

2.  Phaeohyphomycotic cyst of the skin caused by Exophiala jeanselmei.

Authors:  H S Zackheim; C Halde; R S Goodman; S Marchasin; H J Buncke
Journal:  J Am Acad Dermatol       Date:  1985-01       Impact factor: 11.527

Review 3.  Perforating dermatoses: a clinicopathologic review.

Authors:  A H Mehregan
Journal:  Int J Dermatol       Date:  1977 Jan-Feb       Impact factor: 2.736

4.  Concepts of granulomatous inflammation.

Authors:  B C Hirsh; W C Johnson
Journal:  Int J Dermatol       Date:  1984-03       Impact factor: 2.736

Review 5.  Pathology of granulomatous diseases. Mixed inflammatory granulomas.

Authors:  B C Hirsh; W C Johnson
Journal:  Int J Dermatol       Date:  1984-11       Impact factor: 2.736

6.  Lobomycosis. Report of the eighth Colombian case and review of the literature.

Authors:  D Jaramillo; A Cortés; A Restrepo; M Builes; M Robledo
Journal:  J Cutan Pathol       Date:  1976       Impact factor: 1.587

7.  Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology.

Authors:  M R McGinnis
Journal:  J Am Acad Dermatol       Date:  1983-01       Impact factor: 11.527

  7 in total
  14 in total

1.  Eighty Years of Mycopathologia: A Retrospective Analysis of Progress Made in Understanding Human and Animal Fungal Pathogens.

Authors:  Vishnu Chaturvedi; Jean-Philippe Bouchara; Ferry Hagen; Ana Alastruey-Izquierdo; Hamid Badali; Anamelia Lorenzetti Bocca; Jose F Cano-Lira; Cunwei Cao; Sudha Chaturvedi; Sanjay H Chotirmall; Anne D van Diepeningen; Jean-Pierre Gangneux; Jesus Guinea; Sybren de Hoog; Macit Ilkit; Rui Kano; Weida Liu; Nilce M Martinez-Rossi; Marcia de Souza Carvalho Melhem; Mario Augusto Ono; Yuping Ran; Stephane Ranque; Celia Maria de Almeida Soares; Takashi Sugita; Philip A Thomas; Anna Vecchiarelli; Nancy L Wengenack; Patrick C Y Woo; Jianping Xu; Rosely M Zancope-Oliveira
Journal:  Mycopathologia       Date:  2018-11-30       Impact factor: 2.574

2.  The cell wall fraction from Fonsecaea pedrosoi stimulates production of different profiles of cytokines and nitric oxide by murine peritoneal cells in vitro.

Authors:  Yanna Karla de Medeiros Nóbrega; Viviane Furlan Lozano; Tarciane Silva de Araújo; Daniel Diniz de Carvalho; Anamélia Lorenzetti Bocca
Journal:  Mycopathologia       Date:  2010-03-30       Impact factor: 2.574

Review 3.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  The in vitro susceptibility of Fonsecaea pedrosoi to activated macrophages.

Authors:  S Rozental; C S Alviano; W de Souza
Journal:  Mycopathologia       Date:  1994-05       Impact factor: 2.574

5.  Chromoblastomycosis: tissue modifications during itraconazole treatment.

Authors:  Kátia Sheylla Malta Purim; Murilo Calvo Peretti; José Fillus; Marcia Olandoski
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

6.  The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease.

Authors:  Solange Corrêa Garcia Pires d'Avila; Carla Pagliari; Maria Irma Seixas Duarte
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

7.  Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin.

Authors:  Anamelia L Bocca; Patrícia P M S Brito; Florêncio Figueiredo; Carlos Eduardo Tosta
Journal:  Mycopathologia       Date:  2006-04       Impact factor: 2.574

8.  Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole.

Authors:  C D M P e Silva de Azevedo; O Bruña-Romero; S G Marques; F R F do Nascimento; M C Pinto; L A Silva; L E M Bouillet; F S de Azevedo; M A de Resende Stoianoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-15       Impact factor: 3.267

Review 9.  Chromoblastomycosis.

Authors:  Paweł M Krzyściak; Małgorzata Pindycka-Piaszczyńska; Michał Piaszczyński
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

10.  Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.

Authors:  Rowena Alves Coelho; Fábio Brito-Santos; Maria Helena Galdino Figueiredo-Carvalho; Juliana Vitoria Dos Santos Silva; Maria Clara Gutierrez-Galhardo; Antonio Carlos Francesconi do Valle; Rosely Maria Zancopé-Oliveira; Luciana Trilles; Wieland Meyer; Dayvison Francis Saraiva Freitas; Rodrigo Almeida-Paes
Journal:  PLoS Negl Trop Dis       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.